Eiko Lifesciences Q4 Results
- BSE: 540204
- NSE: -
- ISIN: INE666Q01016
- Sector: Chemical Manufacturing
BSE
49.23
0.30 (0.61%)
0.30 (0.61%)Volume11.35 K
Updated: Wed 15 Jul, 2026 | 14:01:45
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
- Total Income₹18.34 Cr.(62.72%)
- Operating Profit₹2.03 Cr.(44.80%)
- Profit After Tax₹1.30 Cr.(24.39%)
- Operating Margin11.09%(-11.01%)
Note: Comparison is on YoY basis
Quarterly - Eiko Lifesciences Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 16.31 | 10.36 | 57.36% | 8.06 | 65.27% |
| Depreciation/ Amortization | 0.25 | 0.26 | -1.02% | 0.18 | 0.92% |
| Operating Income | 2.03 | 1.62 | 25.44% | 0.34 | 44.80% |
| Net Income | 1.30 | 1.21 | 7.77% | 0.31 | 24.39% |
| Other Operating Expenses Total | 0.78 | 0.70 | 12.37% | 0.08 | 6.70% |
| Net Income Before Taxes | 2.02 | 1.90 | 6.12% | 0.42 | 23.32% |
| Total Revenue | 18.34 | 11.98 | 53.04% | 8.40 | 62.72% |
| Selling/ General/ Admin Expenses Total | 0.21 | 0.20 | 6.13% | 0.05 | 95.39% |
| Diluted Normalized EPS | 0.86 | 0.88 | -2.27% | 0.26 | 46.02% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.